Immune checkpoints in cardiac physiology and pathology: therapeutic targets for heart failure
2024 · Nature Reviews Cardiology · 37 citations
https://doi.org/10.1038/s41569-023-00986-9
T
Tamás G. Gergely
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
36
Papers
395
Citations
10
h-index
11
i10-index
Tamás G. Gergely is an academic researcher from Gottsegen National Cardiovascular Center. The author has contributed to research in topics: Heart Failure Treatment and Management & Cardiovascular Function and Risk Factors & Cancer Immunotherapy and Biomarkers. The author has an h-index of 10, co-authored 31 publications.
ORCID: 0000-0003-1972-2065Papers by this author
worksMolecular fingerprints of cardiovascular toxicities of immune checkpoint inhibitors
2024 · Basic Research in Cardiology · 32 citations
https://doi.org/10.1007/s00395-024-01068-8
IL-1β neutralization prevents diastolic dysfunction development, but lacks hepatoprotective effect in an aged mouse model of NASH
2023 · Scientific Reports · 19 citations
https://doi.org/10.1038/s41598-022-26896-3
Reduced circulating CD63+ extracellular vesicle levels associate with atherosclerosis in hypercholesterolaemic mice and humans
2024 · Cardiovascular Diabetology · 10 citations
https://doi.org/10.1186/s12933-024-02459-w
Effect of hypercholesterolemia on circulating and cardiomyocyte-derived extracellular vesicles
2024 · Scientific Reports · 9 citations
https://doi.org/10.1038/s41598-024-62689-6
Comparison of Mouse Models of Heart Failure with Reduced Ejection Fraction
2024 · ESC Heart Failure · 9 citations
https://doi.org/10.1002/ehf2.15031
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat